$NUTX Balance Sheet | Understand Stock

$NUTX

$208.25 -$0.75 (0.36%) Close

$NUTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Restricted short-term investments
Accounts receivable
Nonrelated Party
Related Party
Total accounts receivable
Accounts receivable - related parties
Stock subscriptions receivable
Inventories
Income tax receivable
Prepaid expenses and other current assets
Total current assets

Property and equipment, net (accumulated depreciation of 33,598 and 31,696 as of June 30, 2026 and December 31, 2025, respectively)
Operating lease right-of-use assets
Investment in ACMG
Financing lease right-of-use assets
Intangible assets, net
Goodwill, net
Deposits and other assets
Deferred tax assets
Other assets
Total assets

Liabilities and Equity
Current liabilities:
Accounts payable and accrued expenses
Customer deposits
Accrued interest on notes payable
Due to related parties
Accounts payable
Nonrelated Party
Related Party
Total accounts payable
Accounts payable - related parties
Lines of credit
Current portion of notes payable
Current portion of long-term debt
Operating lease liabilities, current portion
Deferred revenue
Financing lease liabilities, current portion
Accrued arbitration expenses
Accrued income tax expense
Accrued stock-based compensation
Accrued expenses and other current liabilities
Total current liabilities

Long-term debt, net
Warrant liability
Non-current operating lease liabilities, net
Non-current financing lease liabilities, net
Notes payable
Deferred tax liabilities
Total liabilities
Equity:
Preferred stock, $.001 par value; authorized - 100,000,000 shares; issued and outstanding - 0 shares as of March 31, 2021 and December 31, 2021, respectively
Common stock, $0.001 par value; 950,000,000 shares authorized; 6,951,622 and 5,511,452 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively
Additional paid-in capital
Accumulated deficit
Nutex Health Inc. equity
Noncontrolling interests
Total equity

Total liabilities and equity

Comments